Free Shipping Within the US
Money Back Guarantee

Cannabinol methyl ether (CBNM)

Dale blog imageAuthor: Dale Hewett
Table of Contents (Scrollable)


Belonging to the cannabinol (CBN) family, cannabinol methyl ether (CBNM) is one of the purest compounds found in the cannabis plant.

It has a crystalline form and is one of the compounds that can be easily isolated. Although similar to the THC family with its phytocannabinoid properties, it has nothing else in common with those compounds.

Research has shown that its nearest approximation in relation to chemical structure is the mother group known as cannabinol (CBN).

With no specific date as to who or when CBNM was discovered, it is believed that following the original discovery of cannabinol (CBN) in 1940 by Robert S. Chan, researchers stumbled upon the CBNM during the study of the multiple compounds and strains of cannabinoid or terpene that exist in the cannabis plant.

The isolation of compounds for the study is how the CBNM was discovered. 

Related: CBN vs CBD

Like every other compound found in the cannabis plant, CBNM is formed naturally from the mother plant. It is formed from the same precursor as other CBN compounds, i.e., the oxidation of CBNA gotten from cannabigerovarinic acid (CBGVA).

Research has shown that the CBNM is a canonical form of the CBN. 

Unraveling the potentials of CBNM is an ongoing phase of work. Researchers cannot pinpoint the exact function of this compound. If the compound does act like CBN, it is safe to assume that its future in the field is guaranteed considering how functional the CBN is in treating bacterial, inflammation, etc.

The medical world is pushing for more research into the cannabis plant, but the constant misuse and abuse by society has been a constant defense for governments and medical boards like the FDA, UN Convention on Psychotropic Substances, etc. to put a stop to the use of marijuana.


Due to the lack of clinical trials and tests done on CBNM, there are no specifics to what this compound can or cannot do.

Researchers do not yet know how it works or what functions its unique features will make it perform.

There is no test to show how the CBNM works in the human body, what reaction, and what diseases it can be used to treat. 


Unlike the psychoactive THC group of the cannabis plant used in treating neuropathic pains, CBN is used for more subliminal purposes like fighting insomnia, burns wound, bacteria, appetite stimulation, amongst others.

Since the CBN belongs to this group of cannabinoids and is formed through the oxidization of CBNA, it is safe to assume or speculate that they will also have the same effect.

The degree of its potentiality is what we hope the continuous research will provide for the field and the betterment of medicine and relating fields of study.


  • It has a mass of 324.464 g/mol.
  • It is a canonicalized compound.
  • It is a single covalent bond compound with an atom count of 24.
  • It is formed through the oxidation of cannabinolic acid (CBNA).

Cbd Products For Sale Banner


Grotenhermen, F (2003). “Pharmacokinetics and pharmacodynamics of cannabinoids“. Clin Pharmacokinet. 42 (4): 327–60. doi:10.2165/00003088-200342040-00003. PMID 12648025.

Pauling, Linus (1960). “The Concept of Resonance”. The Nature of the Chemical Bond – An Introduction to Modern Structural Chemistry (3rd ed.). Cornell University Press. pp. 10–13. ISBN978-0801403330

National Center for Biotechnology Information. PubChem Compound Summary for CID 628150, Cannabinol methyl derivative. 

Back to List of Cannabinoids

blog BG
Table of Contents

Search our website for more information on CBD:

Related Cannabinoids

Commitment to Trusted Information on CBD

When it comes to understanding both the science and benefits of cannabidiol (CBD), it is extremely important that you can trust the source of your information. This is exactly why our team at New Phase Blends includes experts in the field of cannabinoid research and development, including frequent correspondence with certified medical professionals and PhDs in relevant fields via studies, research, and additional peer reviewed pieces of information. All information published is reviewed and checked for accuracy. We pride ourselves on staying up-to-date with the latest scientific research and clinical studies related to not only CBD, but also its effects on the human body.

Our website also includes an About Us page, where you can learn more about our team, mission, and commitment to providing accurate, reliable information about CBD. Users can access this from the header menu at the top of the screen. Additionally, all of our products are third-party lab tested for quality and purity, and we make the results of these tests easily accessible to our customers.

User Experience Strengthened Through The Use of AI Content

Some articles you read may contain content created by the use of AI tools. This content is always edited by a human. We fact check any AI content, and ensure the information produced is accurate, up to date, and relevant to the article it may be contained in. All content is verified against peer reviewed data on CBD written by PhD’s and respective experts in their field of medical science.

Our goal in using AI content is to increase the user experience by increasing content production, and quality. This results in more information becoming available to the reader more frequently.

About the Author - CBD Expert Dale Hewett

Dale Hewett Author
Dale Hewett

Dale Hewett is the owner and founder of New Phase Blends. He discovered his passion for CBD use after suffering from injuries sustained while on Active Duty in the US Army. His number one priority is introducing the same CBD products that he himself uses for relief to others who can benefit from them.

Dale holds a Master Degree of Science, and is the inventor of the popular, CBD-based sleep aid known as ‘Sleep.’ He’s given multiple lectures on CBD to institutions such as Cornell’s MBA student program, and Wharton’s School of Business.

la wire logo
yahoo finance greyscale
forbes logo
Markets Insider Logo
chicago journal logo greyscale